Linguistic validation of the Spanish version of the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Supportive Care in Cancer

Volumn 24, Issue 7, 2016, Pages 2843-2851

  Arnold, Benjamin ^a   Mitchell, Sandra A ^b   Lent, Lauren ^a   Mendoza, Tito R ^c   Rogak, Lauren J ^d   Barragán, Natalie M ^d   Willis, Gordon ^b   Medina, Mauricio ^e   Lechner, Suzanne ^f   Penedo, Frank J ^g   Harness, Jay K ^h   Basch, Ethan M ^d,i  

^a FACITtrans   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f UNIVERSITY OF MIAMI   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h ST JOSEPH HOSPITAL   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Adverse events; Cancer; Patient Reported outcomes; PRO CTCAE; Spanish; Toxicity; Translation

Indexed keywords

ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CULTURAL FACTOR; EDUCATIONAL STATUS; FEMALE; HUMAN; LINGUISTICS; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH ORGANIZATION; PATIENT REPORTED OUTCOMES VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS; PRIORITY JOURNAL; SAMPLE SIZE; SELF REPORT; VALIDATION STUDY; ADVERSE DRUG REACTION; COMPLICATION; MIDDLE AGED; NEOPLASM; PATIENT-REPORTED OUTCOME; PROCEDURES; QUESTIONNAIRE; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; LINGUISTICS; MALE; MIDDLE AGED; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; PATIENT REPORTED OUTCOME MEASURES; SELF REPORT; SURVEYS AND QUESTIONNAIRES; UNITED STATES; YOUNG ADULT;

EID: 84970016057     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-015-3062-5     Document Type: Article

References (20)

1. National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. NIH publication # 09-7473. Published May 29, 2009; Revised Version 4.02 September 15, 2009. Available at http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.02_2009-09-15_QuickReference_5x7.pdf (last accessed 7/25/15)
2. National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. caBIG Knowledge Center, CTCAE FAQ. Available at https://cabig-kc.nci.nih.gov/Vocab/KC/index.php/CTCAE_FAQ (last accessed 7/25/15)
3. Basch EM, Reeve BB, Mitchell SA, Clauser SB, Minasian L, Sit L, Chilukuri R, Baumgartner P, Rogak L, Blauel E, Abernethy AP, Bruner D (2011) Electronic toxicity monitoring and patient-reported outcomes. Cancer J 17(4):231–234
4. Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O’Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, Rogak L, Barz A, Paul DB, Schrag D (2014) Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst 106(9):dju244
5. Hay JL, Atkinson TM, Reeve BB, Mitchell SA, Mendoza TR, Willis G, Minasian LM, Clauser SB, Denicoff A, O’Mara A, Chen A, Bennett AV, Paul DB, Gagne J, Rogak L, Sit L, Viswanath V, Schrag D, Basch E (2014) NCI PRO-CTCAE Study Group. Cognitive interviewing of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Qual Life Res 23(1):257–269
6. Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, Atkinson TM, Bennett AV, Denicoff AM, O’Mara AM, Li Y, Clauser SB, Bryant DM, Bearden JD, Gillis TA, Harness JK, Siegel RD, Paul DB, Cleeland CS, Schrag D, Sloan JA, Abernethy AP, Bruner DW, Minasian LM, Basch E (2015) Validity and reliability of the U.S. National Cancer Institute’s patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. doi:10.1001/jamaoncol.2015.2639. Published online August 13, 2015
7. Eremenco SL, Cella D, Arnold BJ (2005) A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof 28(2):212–232
8. Wild D, Grove A, Martin M, Eremenco S, Ford S, Verjee-Lorenz A et al (2005) Principles of good practice for the translation and cultural adaptation process for patient reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 8(2):94–104
9. Mullin V, Cella D, Chang CH, Eremenco S, Mertz M, Lent L, Falkson C, Falkson G (2000) Development of three African language translations of the FACT-G. Qual Life Res 9(2):139–149
10. Bonomi AE, Cella DF, Hahn EA, Bjordal K, Sperner-Unterweger B, Gangeri L, Bergman B, Willems-Groot J, Hanquet P, Zittoun R (1996) Multilingual translation of the functional assessment of cancer therapy (FACT) quality of life measurement system. Qual Life Res 5(3):309–320
11. Flaherty JA, Gaviria FM, Pathak D, Mitchell T, Wintrob R, Richman JA, Birz S (1988) Developing instruments for cross-cultural psychiatric research. J Nerv Ment Dis 176(5):257–263
12. Willis GB (2015) Analysis of the cognitive interview in questionnaire design. Oxford, New York
13. Reeve BB, Mitchell SA, Dueck AC, Basch E, Cella D, Reilly CM, Minasian LM, Denicoff AM, O’Mara AM, Fisch MJ, Chauhan C, Aaronson NK, Coens C, Bruner DW (2014) Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst 8:106(7)
14. Wallen GR, Feldman RH, Anliker J (2002) Measuring acculturation among Central American women with the use of a brief language scale. J Immigr Health 4(2):95–102
15. Willis GB (2005) Cognitive interviewing: a tool for improving questionnaire design. SAGE Publications, Inc., Thousand Oaks, CA
16. Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L (2011) Content validity—establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2—assessing respondent understanding. Value Health 14(8):978–988
17. Ennis SR, Rios-Vargas M, Albert NG. The Hispanic Population: 2010, 2011; http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf (last accessed 7/25/15)
18. Bennett AV, Dueck AC, Mitchell SA, Mendoza TR, Reeve BB, Atkinson TM, Castro KM, Denicoff A, Rogak LJ, Harness JK, Bearden JD, Bryant D, Siegel RD, Schrag D, Basch E. Mode equivalence and acceptability of web-, interactive voice response system-, and paper-based administration of U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Presented at International Society for Quality of Life Research (ISOQOL): October 12, 2013; Miami, FL, USA
19. Wilson MK, Collyar D, Chingos DT, Friedlander M, Ho TW, Karakasis K, Kaye S, Parmar MK, Sydes MR, Tannock IF, Oza AM (2015) Outcomes and endpoints in cancer trials: bridging the divide. Lancet Oncol 16(1):e43–e52
20. Basch E, Abernethy AP, Mullins CD, Reeve BB, Smith ML, Coons SJ, Sloan J, Wenzel K, Chauhan C, Eppard W, Frank ES, Lipscomb J, Raymond SA, Spencer M, Tunis S (2012) Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol 30(34):4249–4255